Clicky

BriaCell Therapeutics Corp.(BCTX) News

Date Title
Jun 25 Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation
Jun 24 BriaCell Up in U.S. Pre-market, as Data Safety Board Review Recommends Phase 3 Study Continues
Jun 24 BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer
Apr 10 BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3
Feb 11 BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Jan 3 BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025
Jan 3 BriaCell Announces Proposed Effective Date of Share Consolidation
May 15 BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering
Apr 24 BriaCell Announces Oral and Poster Presentations at ASCO 2024
Apr 10 BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
Apr 9 BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR
Mar 7 BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
Mar 6 BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
Feb 27 BriaCell Provides Update on Alleged Illegal Trading of Public Securities
Jan 4 BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer
Dec 28 BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients
Dec 20 BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset
Dec 18 BCTX: Down in San Antone
Dec 6 BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS
Dec 6 BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit